Synlett 2018; 29(10): 1289-1292
DOI: 10.1055/s-0036-1591847
letter
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Asparagusic Acid Modified Lysine and its Application in Solid-Phase Synthesis of Peptides with Enhanced Cellular Uptake

Alina Tirla
Laboratorium für Organische Chemie, ETH Zürich, HCI G329, Vladimir-Prelog-Weg 3, 8093 Zürich, Switzerland   Email: pablo.rivera-fuentes@org.chem.ethz.ch
,
Moritz Hansen
Laboratorium für Organische Chemie, ETH Zürich, HCI G329, Vladimir-Prelog-Weg 3, 8093 Zürich, Switzerland   Email: pablo.rivera-fuentes@org.chem.ethz.ch
,
Pablo Rivera-Fuentes*
Laboratorium für Organische Chemie, ETH Zürich, HCI G329, Vladimir-Prelog-Weg 3, 8093 Zürich, Switzerland   Email: pablo.rivera-fuentes@org.chem.ethz.ch
› Author Affiliations
This work was supported by the Swiss National Science Foundation (grant 200021_165551).
Further Information

Publication History

Received: 02 October 2017

Accepted after revision: 07 November 2017

Publication Date:
08 December 2017 (online)


Published as part of the Special Section 9th EuCheMS Organic Division Young Investigator Workshop

Abstract

Cyclic disulfides, such as asparagusic acid, enhance the uptake of a variety of cargoes into live cells. Here, we report a robust and scalable synthesis of an asparagusic acid modified lysine. This amino acid can be used in solid-phase peptide synthesis. We confirmed that incorporation of this building block into the sequence of a peptide increases its cellular uptake substantially.

Supporting Information

 
  • References and Notes

  • 1 Torres AG. Gait MJ. Trends Biotechnol. 2012; 30: 185
  • 2 Stewart MP. Sharei A. Ding X. Sahay G. Langer R. Jensen KF. Nature 2016; 538: 183
  • 3 Allen TM. Cullis PR. Adv. Drug Delivery Rev. 2013; 65: 36
  • 4 Ma Y. Nolte RJ. M. Cornelissen JJ. L. M. Adv. Drug Delivery Rev. 2012; 64: 811
  • 5 Haag R. Kratz F. Angew. Chem. Int. Ed. 2006; 45: 1198
  • 6 Bechara C. Sagan S. FEBS Lett. 2013; 587: 1693
  • 7 Fonseca SB. Pereira MP. Kelley SO. Adv. Drug Delivery Rev. 2009; 61: 953
  • 8 Bruce VJ. McNaughton BR. Cell Chem. Biol. 2017; 24: 924
  • 9 Gasparini G. Sargsyan G. Bang EK. Sakai N. Matile S. Angew. Chem. Int. Ed. 2015; 54: 7328
  • 10 Gasparini G. Bang E.-K. Molinard G. Tulumello DV. Ward S. Kelley SO. Roux A. Sakai N. Matile S. J. Am. Chem. Soc. 2014; 136: 6069
  • 11 Abegg D. Gasparini G. Hoch DG. Shuster A. Bartolami E. Matile S. Adibekian A. J. Am. Chem. Soc. 2017; 139: 231
  • 12 Chuard N. Gasparini G. Moreau D. Lörcher S. Palivan C. Meier W. Sakai N. Matile S. Angew. Chem. Int. Ed. 2017; 56: 2947
  • 13 Derivery E. Bartolami E. Matile S. Gonzalez-Gaitan M. J . Am. Chem. Soc. 2017; 139: 10172
  • 14 Venditti A. Mandrone M. Serrilli AM. Bianco A. Iannello C. Poli F. Antognoni F. J. Agric. Food Chem. 2013; 61: 6848
  • 15 Yanagawa H. Kato T. Sagami H. Kitahara Y. Synthesis 1973; 607
  • 16 N 2-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-N 6-(1,2-dithiolane-4-carbonyl)-l-lysine (Fmoc-Lys(AspA)-OH, 6) Crude NHS ester 5 (328 mg, 1.32 mmol) was dissolved in dioxane-PBS, 3:1 (28 mL) at room temperature (25 °C) and Fmoc-Lys-OH (538 mg, 1.46 mmol, 1.1 equiv) was added in one portion. After 4 h, the solution was acidified by slow addition of 1 M HCl (ca. 2 mL) and CH2Cl2 (ca. 25 mL) until phase separation occurred. The aqueous phase was extracted again with CH2Cl2 (2 × 25 mL). A white emulsion formed, which could be separated by centrifugation (3 min at 1750 × G). The combined organic phases were dried over MgSO4, filtered, and concentrated under reduced pressure to give a very viscous light-yellow oil. The product was precipitated from pentane. The obtained solid was purified by flash column chromatography (SiO2; CH2Cl2–MeOH, 100 to 90:10) to give a white solid (198 mg, 30% yield). 1H NMR (400 MHz, DMSO-d 6): δ = 1.24–1.46 (m, 4 H, H-5 and H-6), 1.54–1.76 (m, 2 H, H-7), 2.98–3.22 (m, 5 H, H-4, H-2, two of H-1), 3.37 (m, 2 H, two of H-1), 3.86–3.95 (m, 1 H, H-8), 4.19–4.26 (m, 1 H, H-11), 4.25–4.30 (m, 2 H, H-10), 7.33 (td, J = 7.4, 1.1 Hz, 2 H, H-13), 7.42 (td, J = 7.5, 1.6 Hz, 2 H, H-14), 7.59 (d, J = 8.0 Hz, 1 H, H-9), 7.73 (d, J = 7.5 Hz, 2 H, H-12), 7.89 (d, J = 7.5 Hz, 2 H, H-15), 8.11 (t, J = 5.6 Hz, 1 H, H-3) ppm. 13C NMR (101 MHz, DMSO-d 6): δ = 23.5, 28.9, 30.8, 39.0, 42.5, 42.6, 47.1, 52.0, 54.1, 66.0, 120.5, 120.6, 125.7, 125.8, 127.5 (2 C), 128.1 (2 C), 141.1, 141.2, 144.2, 144.3, 156.6, 170.6, 174.4 ppm. ESI-HRMS: m/z calcd for [C25H28N2O5S2Na]+: 523.1332; found: 523.1340.